Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to $74.5 million.

  • Phibro Animal Health's Cash & Current Investments rose 1108.33% to $74.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $74.5 million, marking a year-over-year increase of 1108.33%. This contributed to the annual value of $77.0 million for FY2025, which is 3278.34% down from last year.
  • According to the latest figures from Q4 2025, Phibro Animal Health's Cash & Current Investments is $74.5 million, which was up 1108.33% from $85.3 million recorded in Q3 2025.
  • In the past 5 years, Phibro Animal Health's Cash & Current Investments ranged from a high of $114.6 million in Q2 2024 and a low of $67.1 million during Q4 2024
  • Moreover, its 5-year median value for Cash & Current Investments was $90.5 million (2023), whereas its average is $87.4 million.
  • As far as peak fluctuations go, Phibro Animal Health's Cash & Current Investments surged by 4100.84% in 2024, and later plummeted by 3278.34% in 2025.
  • Over the past 5 years, Phibro Animal Health's Cash & Current Investments (Quarter) stood at $95.5 million in 2021, then decreased by 17.87% to $78.4 million in 2022, then increased by 17.94% to $92.5 million in 2023, then decreased by 27.48% to $67.1 million in 2024, then increased by 11.08% to $74.5 million in 2025.
  • Its Cash & Current Investments was $74.5 million in Q4 2025, compared to $85.3 million in Q3 2025 and $77.0 million in Q2 2025.